NEW YORK (GenomeWeb News) – Sequenom said today that the underwriters of its recently completed public offering of common stock have exercised an option to acquire an additional 825,000 shares.

 

Last week, the firm offered 5.5 million shares of common stock at $15.50 per share.

 

The exercise of the over-allotment option brings the total number of shares sold to 6,325,000 and net proceeds to $92 million.